A Multi-Dose Study With a Treatment for Open-Angle Glaucoma | NCT00705770 | Trialant
WithdrawnInterventionalPhase 2Phase 3Updated May 30, 2012
A Multi-Dose Study With a Treatment for Open-Angle Glaucoma
ClinicalTrials.gov ID
NCT00705770
Lead Sponsor
Alcon ResearchINDUSTRY
Overall Status
Withdrawn
Study Type
Interventional
Phase
Phase 2Phase 3
Enrollment
0Actual
Last Update Posted
May 30, 2012Estimated
Start Date
May 2008
Primary Completion Date
Jul 2008Actual
Completion Date
Jul 2008Actual
Brief Summary
The purpose of this study is to determine whether Anecortave Acetate is effective for lowering intraocular pressure caused by open-angle glaucoma.
Open-Angle Glaucoma
Anecortave Acetate
Placebo
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients at least 18 years old with a clinical diagnosis of Open-Angle Glaucoma for at least 6 months and currently treated with a monotherapy hypotensive medication
Exclusion Criteria:
Prior angle surgery in the study eye, severe visual field loss in either eye, and any other form of glaucoma besides open-angle glaucoma